WHO widened its medical device prequalification program on September 30. Until now it ran on in vitro diagnostics and male circumcision devices. The new categories are male and female condoms, intrauterine devices, and computer-aided detection software for tuberculosis screening. Male circumcision devices move into the broader framework.
Prequalification is an independent assessment against international quality, safety and performance standards. UN agencies, procurement organizations, donors and national health authorities use the list to decide what they buy. That matters most in the roughly 70 percent of countries WHO describes as lacking adequate regulatory capacity. WHO has published submission requirements and timelines, and contraceptive devices, CAD-TB products and male circumcision devices make up the first assessment wave.
For a startup this is a procurement gate, not a regulatory one. A CAD-TB listing puts the product in front of the same buyers who work off WHO's drug and diagnostic lists. In markets with no national review to lean on, it is the shortest route in.